Skip to main content

Cohen Neil Harris's Form 4 filing

Chemomab Therapeutics Ltd. (CMMB) · filed Nov 18, 2022

Accession no.
0001178913-22-004100
Filed
Nov 18, 2022
Trade date
Mar 16, 2021-Nov 16, 2022
Filing delay
612 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 3 derivative transactions. Open-market sales total $4.82K. It was filed 612 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cohen Neil HarrisCIK 0001840006Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 16, 2022American Depositary SharesSSaleDisposed−2,409$2.00−$4,81810,000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 7, 2022American Depositary SharesAGrant or awardAcquired+6,820$0.00$06,820DirectDuplicate filing
Apr 19, 2021American Depositary SharesAGrant or awardAcquired+11,884$0.00$011,884DirectDuplicate filing
Mar 16, 2021American Depositary SharesAGrant or awardAcquired+688$0.00$0688DirectDuplicate filing

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)